Send password reminder...
Subscribe to New Research on AG 1517
Also Known As:
relevant articles (
Bio-Agent Context: Research Results
Heterocyclic Compounds: 60
2-Ring Heterocyclic Compounds
AG 1517: 1
Psoriasis (Pustulosis Palmaris et Plantaris)
05/01/1999 - "
AG 1517 (SU 5271), a potent epiderminal growth factor receptor kinase inhibitor, is currently in clinical trials for psoriasis.
Related Drugs and Biologics
CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
We wish to acknowledge and thank the US National Library of Medicine and Medline staff for providing access to their data.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.